Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Italy Spain
  • Comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Lithuania Poland
  • Study on Retinoblastoma Treatment Using Etoposide, Carboplatin, and Melphalan for Patients with Specific Eye Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

    Recruiting

    2 1 1
    France
  • Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Italy Poland Portugal Romania Spain
  • Study on Long-Term Use of Infigratinib for Children with Achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Norway Spain
  • Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain
  • Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Portugal Spain